These results reveal a new function of calcium channels in IDO1‐mediated tryptophan metabolism in tumor immunity and warrant further development of lacidipine as a safer and more effective metabolic immunotherapy for breast cancer. The gene discussed is IDO1; the disease is breast cancer.